Potential therapeutic targets in Crohn's disease

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2002

Schlagwörter:	Tumour Necrosis Factor Leucine Inflammatory Cytokine Nuclear Factor Normal Function

Anmerkung:	© Adis International Ltd 2002

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1327(2002), 1 vom: März, Seite 2-2
Übergeordnetes Werk:	volume:1327 ; year:2002 ; number:1 ; month:03 ; pages:2-2

Links:	Volltext

DOI / URN:	10.2165/00128413-200213270-00001

Katalog-ID:	SPR035121807

Internformat


LEADER	01000caa a22002652 4500
001	SPR035121807
003	DE-627
005	20230519142016.0
007	cr uuu---uuuuu
008	201007s2002 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200213270-00001 \|2 doi
035			\|a (DE-627)SPR035121807
035			\|a (SPR)00128413-200213270-00001-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Potential therapeutic targets in Crohn's disease
264		1	\|c 2002
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2002
650		4	\|a Tumour Necrosis Factor \|7 (dpeaa)DE-He213
650		4	\|a Leucine \|7 (dpeaa)DE-He213
650		4	\|a Inflammatory Cytokine \|7 (dpeaa)DE-He213
650		4	\|a Nuclear Factor \|7 (dpeaa)DE-He213
650		4	\|a Normal Function \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1327(2002), 1 vom: März, Seite 2-2 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1327 \|g year:2002 \|g number:1 \|g month:03 \|g pages:2-2
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200213270-00001 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
951			\|a AR
952			\|d 1327 \|j 2002 \|e 1 \|c 03 \|h 2-2

Indexfelder

matchkey_str	article:22306056:2002----::oetateaetcagtic
hierarchy_sort_str	2002
publishDate	2002
allfields	10.2165/00128413-200213270-00001 doi (DE-627)SPR035121807 (SPR)00128413-200213270-00001-e DE-627 ger DE-627 rakwb eng Potential therapeutic targets in Crohn's disease 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Tumour Necrosis Factor (dpeaa)DE-He213 Leucine (dpeaa)DE-He213 Inflammatory Cytokine (dpeaa)DE-He213 Nuclear Factor (dpeaa)DE-He213 Normal Function (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1327(2002), 1 vom: März, Seite 2-2 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1327 year:2002 number:1 month:03 pages:2-2 https://dx.doi.org/10.2165/00128413-200213270-00001 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1327 2002 1 03 2-2
spelling	10.2165/00128413-200213270-00001 doi (DE-627)SPR035121807 (SPR)00128413-200213270-00001-e DE-627 ger DE-627 rakwb eng Potential therapeutic targets in Crohn's disease 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Tumour Necrosis Factor (dpeaa)DE-He213 Leucine (dpeaa)DE-He213 Inflammatory Cytokine (dpeaa)DE-He213 Nuclear Factor (dpeaa)DE-He213 Normal Function (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1327(2002), 1 vom: März, Seite 2-2 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1327 year:2002 number:1 month:03 pages:2-2 https://dx.doi.org/10.2165/00128413-200213270-00001 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1327 2002 1 03 2-2
allfields_unstemmed	10.2165/00128413-200213270-00001 doi (DE-627)SPR035121807 (SPR)00128413-200213270-00001-e DE-627 ger DE-627 rakwb eng Potential therapeutic targets in Crohn's disease 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Tumour Necrosis Factor (dpeaa)DE-He213 Leucine (dpeaa)DE-He213 Inflammatory Cytokine (dpeaa)DE-He213 Nuclear Factor (dpeaa)DE-He213 Normal Function (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1327(2002), 1 vom: März, Seite 2-2 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1327 year:2002 number:1 month:03 pages:2-2 https://dx.doi.org/10.2165/00128413-200213270-00001 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1327 2002 1 03 2-2
allfieldsGer	10.2165/00128413-200213270-00001 doi (DE-627)SPR035121807 (SPR)00128413-200213270-00001-e DE-627 ger DE-627 rakwb eng Potential therapeutic targets in Crohn's disease 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Tumour Necrosis Factor (dpeaa)DE-He213 Leucine (dpeaa)DE-He213 Inflammatory Cytokine (dpeaa)DE-He213 Nuclear Factor (dpeaa)DE-He213 Normal Function (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1327(2002), 1 vom: März, Seite 2-2 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1327 year:2002 number:1 month:03 pages:2-2 https://dx.doi.org/10.2165/00128413-200213270-00001 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1327 2002 1 03 2-2
allfieldsSound	10.2165/00128413-200213270-00001 doi (DE-627)SPR035121807 (SPR)00128413-200213270-00001-e DE-627 ger DE-627 rakwb eng Potential therapeutic targets in Crohn's disease 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Tumour Necrosis Factor (dpeaa)DE-He213 Leucine (dpeaa)DE-He213 Inflammatory Cytokine (dpeaa)DE-He213 Nuclear Factor (dpeaa)DE-He213 Normal Function (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1327(2002), 1 vom: März, Seite 2-2 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1327 year:2002 number:1 month:03 pages:2-2 https://dx.doi.org/10.2165/00128413-200213270-00001 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1327 2002 1 03 2-2
language	English
source	Enthalten in Inpharma weekly 1327(2002), 1 vom: März, Seite 2-2 volume:1327 year:2002 number:1 month:03 pages:2-2
sourceStr	Enthalten in Inpharma weekly 1327(2002), 1 vom: März, Seite 2-2 volume:1327 year:2002 number:1 month:03 pages:2-2
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Tumour Necrosis Factor Leucine Inflammatory Cytokine Nuclear Factor Normal Function
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2002-03-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR035121807
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035121807</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519142016.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2002 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200213270-00001</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035121807</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200213270-00001-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Potential therapeutic targets in Crohn's disease</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2002</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2002</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tumour Necrosis Factor</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Leucine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Inflammatory Cytokine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nuclear Factor</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Normal Function</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1327(2002), 1 vom: März, Seite 2-2</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1327</subfield><subfield code="g">year:2002</subfield><subfield code="g">number:1</subfield><subfield code="g">month:03</subfield><subfield code="g">pages:2-2</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200213270-00001</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1327</subfield><subfield code="j">2002</subfield><subfield code="e">1</subfield><subfield code="c">03</subfield><subfield code="h">2-2</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Potential therapeutic targets in Crohn's disease Tumour Necrosis Factor (dpeaa)DE-He213 Leucine (dpeaa)DE-He213 Inflammatory Cytokine (dpeaa)DE-He213 Nuclear Factor (dpeaa)DE-He213 Normal Function (dpeaa)DE-He213
topic	misc Tumour Necrosis Factor misc Leucine misc Inflammatory Cytokine misc Nuclear Factor misc Normal Function
spellingShingle	misc Tumour Necrosis Factor misc Leucine misc Inflammatory Cytokine misc Nuclear Factor misc Normal Function Potential therapeutic targets in Crohn's disease
topic_unstemmed	misc Tumour Necrosis Factor misc Leucine misc Inflammatory Cytokine misc Nuclear Factor misc Normal Function
topic_browse	misc Tumour Necrosis Factor misc Leucine misc Inflammatory Cytokine misc Nuclear Factor misc Normal Function
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Potential therapeutic targets in Crohn's disease
ctrlnum	(DE-627)SPR035121807 (SPR)00128413-200213270-00001-e
title_full	Potential therapeutic targets in Crohn's disease
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2002
contenttype_str_mv	txt
container_start_page	2
container_volume	1327
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200213270-00001
title_sort	potential therapeutic targets in crohn's disease
title_auth	Potential therapeutic targets in Crohn's disease
abstract	© Adis International Ltd 2002
abstractGer	© Adis International Ltd 2002
abstract_unstemmed	© Adis International Ltd 2002
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20
container_issue	1
title_short	Potential therapeutic targets in Crohn's disease
url	https://dx.doi.org/10.2165/00128413-200213270-00001
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200213270-00001
up_date	2024-07-03T13:41:20.971Z
_version_	1803565484974538752
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035121807</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519142016.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2002 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200213270-00001</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035121807</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200213270-00001-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Potential therapeutic targets in Crohn's disease</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2002</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2002</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tumour Necrosis Factor</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Leucine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Inflammatory Cytokine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nuclear Factor</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Normal Function</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1327(2002), 1 vom: März, Seite 2-2</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1327</subfield><subfield code="g">year:2002</subfield><subfield code="g">number:1</subfield><subfield code="g">month:03</subfield><subfield code="g">pages:2-2</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200213270-00001</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1327</subfield><subfield code="j">2002</subfield><subfield code="e">1</subfield><subfield code="c">03</subfield><subfield code="h">2-2</subfield></datafield></record></collection>
score	7.400709

Nicht das Richtige dabei?

Schreiben Sie uns!

Potential therapeutic targets in Crohn's disease

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?